Big-Name Drugs Try New Roles In Rheumatism
This article was originally published in The Pink Sheet Daily
Executive Summary
Lilly’s Cymbalta performs well in major osteoarthritis trial.
You may also be interested in...
Lilly Submits Cymbalta For Chronic Pain
If approved for fibromyalgia and chronic pain, drug label would include six indications.
FDA Clears BMS’ Orencia In Juvenile Arthritis
Second indication comes with news of Repligen settlement.
Abbott’s Humira Approved For Juvenile Idiopathic Arthritis
Tumor necrosis factor inhibitor an important option to Wyeth’s Enbrel, Abbott tells “The Pink Sheet” DAILY.